You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,343,995


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,343,995 protect, and when does it expire?

Patent 10,343,995 protects YUPELRI and is included in one NDA.

This patent has thirty-eight patent family members in twenty-seven countries.

Summary for Patent: 10,343,995
Title:Biphenyl compounds useful as muscarinic receptor antagonists
Abstract: This invention provides compounds of formula I: ##STR00001## wherein a, b, c, d, m, n, p, s, t, W, Ar.sup.1, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.6, R.sup.7, and R.sup.8 are as defined in the specification. The compounds of formula I are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders.
Inventor(s): Mammen; Mathai (Menlo Park, CA), Ji; YuHua (Palo Alto, CA), Mu; YongQi (Los Altos, CA), Husfeld; Craig (Redwood City, CA), Li; Li (Sunnyvale, CA)
Assignee: THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA)
Application Number:16/130,076
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,343,995: A Comprehensive Guide

Introduction

When analyzing a patent, particularly one like United States Patent 10,343,995, it is crucial to delve into its scope, claims, and the broader patent landscape. This analysis helps in understanding the patent's validity, potential infringement risks, and its position within the technological field.

Understanding Patent Scope

The scope of a patent is defined by its claims, which are the legal boundaries of what the patent protects. The scope can be measured using metrics such as independent claim length and independent claim count, as discussed in research on patent scope[3].

Independent Claim Length and Count

Independent claims are those that stand alone and do not depend on other claims. The length and count of these claims can indicate the breadth of the patent. Generally, narrower claims with shorter lengths and fewer counts are associated with a higher probability of grant and a shorter examination process[3].

Patent Claims Analysis

Claim Structure

To analyze the claims of US Patent 10,343,995, one must look at the claim structure. This includes identifying independent and dependent claims. Independent claims define the broadest scope of the invention, while dependent claims further limit the scope by adding additional features.

Subjective Claims Terms

When drafting patents, especially those with subjective claims terms, it is essential to provide clear and meaningful examples to avoid indefiniteness. The law requires that claims "particularly point out" and "distinctly" claim the subject matter of the invention. Subjective terms, such as "in an unobtrusive manner," can be problematic if not adequately defined in the specification[5].

Patent Landscape Analysis

Technological Area

A patent landscape analysis provides a comprehensive overview of the patenting activity in a specific technological area. For US Patent 10,343,995, this involves identifying other patents and published applications in the same or related technology fields. This helps in understanding the competitive landscape and potential infringement risks[4].

Prior Art

Prior art includes any public knowledge, publications, or resources that disclose the invention or elements of it before the effective filing date of the patent application. This can include scientific literature, technical reports, trade show pamphlets, product manuals, and previously granted patents or published applications. A thorough search of prior art is crucial to determine the novelty and non-obviousness of the invention[4].

Conducting a Preliminary Patent Search

Tools and Resources

To analyze the scope and claims of US Patent 10,343,995, one can use various tools and resources. The USPTO Public Search Facility and the USPTO Main STIC Library are valuable resources, especially for searching foreign patents. Additionally, databases like PatentsView, which is derived from USPTO public bulk data releases, can provide comprehensive information on published patent applications and granted patents[1][2].

Advanced Search Techniques

Advanced search techniques such as using Boolean operators, classification codes (e.g., IPC, CPC), and citation analysis can refine the search. These methods help in identifying relevant patents and patent applications that may impact the patentability of the invention[4].

Sequence Listings and Mega Items

For patents involving sequences or mega items, such as those in biotechnology or chemistry, the Publication Site for Issued and Published Sequences (PSIPS) website is a useful resource. This site provides access to sequence listings, tables, and other mega items for granted US patents or published US patent applications[1].

Patent Assignment Search

Understanding the ownership and assignment history of a patent is also important. The Patent Assignment Search website allows users to search for patent assignments and changes in ownership, which can be crucial for licensing and litigation purposes[1].

Citation Analysis

Citation analysis involves examining the citations in related patents and patent applications to uncover additional relevant documents. This can provide insights into the technological lineage and the impact of the patent within its field[4].

Practical Implications

Patentability Analysis

A thorough patentability analysis is essential before filing a patent application. This involves searching through databases to find any existing documents, patents, or other public disclosures that might affect the patentability of the invention. This step helps in avoiding the rejection of the patent application due to prior art[4].

Licensing and Litigation

Understanding the scope and claims of a patent also has practical implications for licensing and litigation. Narrower claims may reduce licensing and litigation costs, while broader claims may increase these costs due to potential disputes over patent validity and infringement[3].

Key Takeaways

  • Patent Scope: Defined by claims, with metrics like independent claim length and count indicating breadth.
  • Claim Analysis: Independent and dependent claims define the scope; subjective terms must be clearly defined.
  • Patent Landscape: Analyze technological area and prior art to understand competitive landscape and infringement risks.
  • Search Techniques: Use advanced techniques like Boolean operators and citation analysis.
  • Sequence Listings: Utilize PSIPS for sequence listings and mega items.
  • Assignment Search: Track ownership and assignment history.
  • Practical Implications: Conduct thorough patentability analysis to avoid rejection and understand licensing and litigation implications.

FAQs

Q: What is the importance of independent claim length and count in patent scope analysis?

A: Independent claim length and count are metrics that indicate the breadth of a patent. Narrower claims with shorter lengths and fewer counts are associated with a higher probability of grant and a shorter examination process[3].

Q: How do subjective claims terms affect patent validity?

A: Subjective claims terms can lead to indefiniteness if not adequately defined in the specification. Clear and meaningful examples must be provided to avoid this issue[5].

Q: What resources are available for conducting a preliminary patent search?

A: Resources include the USPTO Public Search Facility, USPTO Main STIC Library, and databases like PatentsView derived from USPTO public bulk data releases[1][2].

Q: Why is prior art important in patent analysis?

A: Prior art includes any public knowledge or resources that disclose the invention before the effective filing date, which can render an invention unpatentable if it is not novel or non-obvious[4].

Q: How does citation analysis help in patent landscape analysis?

A: Citation analysis helps in identifying additional relevant documents by examining citations in related patents and patent applications, providing insights into the technological lineage and impact of the patent[4].

Sources

  1. USPTO: Search for patents - USPTO. (2018, October 18). Retrieved from https://www.uspto.gov/patents/search
  2. PatentsView: Claims Downloads - PatentsView. Retrieved from https://patentsview.org/download/claims
  3. SSRN: Patent Claims and Patent Scope. (2016, September 29). Retrieved from https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Sierra IP Law: Patent Searches - Sierra IP Law. Retrieved from https://sierraiplaw.com/patent-searches/
  5. BIPC: Practical Advice for Drafting Patents with Subjective Claims Terms. (2017, January 31). Retrieved from https://www.bipc.com/practical-advice-for-drafting-patents-with-subjective-claims-terms

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,343,995

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mylan Ireland Ltd YUPELRI revefenacin SOLUTION;INHALATION 210598-001 Nov 9, 2018 RX Yes Yes ⤷  Subscribe ⤷  Subscribe FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.